Akums Drugs And Pharmaceuticals Limited - Company Profile

It is a chemicals public limited company based in Delhi, Delhi, India, established in 2004.
2004 Delhi, Delhi, India Active
Last Updated:
About Akums Drugs And Pharmaceuticals Limited

Akums Drugs And Pharmaceuticals Limited, a active public limited company, was established on 19 April 2004 in Delhi, Delhi, India. Engaging in chemical products within the manufacturing sector, it holds CIN: L24239DL2004PLC125888. Registered under ROC Roc Delhi. it is listed. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹31.48 Cr.

It upholds a compliant status. In 2025, it reported revenue of ₹1,435.98 Cr and a net worth of ₹2,305.25 Cr. Employing 1,575 professional, Its leadership includes Sanjay Sinha (Whole-Time Director), Satwinder Singh (Director), Anilkumar Arvindlal Amin (Director). Past directors included Sanjay Sinha, Narendra Sachdeva Dev, Mata Pher Singh. It holds ₹245.00 Cr open charges and ₹468.39 Cr settled loans. Its latest AGM occurred on 18 July 2025, with the balance sheet filed on 31 March 2025. It is based at 304 Mohan Placelsc Saraswati Vihar, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24239DL2004PLC125888

  • Registration Number

    125888

  • Incorporation Date

    19 April 2004

  • Authorized Capital

    ₹40.00 Cr

  • Paid-Up Capital

    ₹31.48 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Listed

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 31.48 Cr
  • Company Age 21 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 245.00 Cr
  • Satisfied Charges ₹ 468.39 Cr
  • Revenue Growth **** -6.65%
  • Profit Growth **** 197.31%
  • Ebitda **** 209.35%
  • Net Worth 1502.23%
  • Total Assets **** 28.13%
Company report

Akums Drugs And Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Akums Drugs And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Akums Drugs And Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Sinha Whole-Time Director 17 Jan 2024 Current
Satwinder Singh Director 17 Jan 2024 Current
Anilkumar Arvindlal Amin Director 04 Jun 2025 Current
Kewal Kundanlal Handa Director 16 Mar 2022 Current
Sanjeev Jain Managing Director 19 Apr 2004 Current
Matangi Gowrishankar Director 16 Mar 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 06 Feb 2024 Past
Pramod Abcsdd Director 20 Jun 2020 Past
Pramod Abcsdd Whole-Time Director 01 Feb 2014 Past
Pramod Abcsdd Additional Director 27 Sep 2015 Past
Pramod Abcsdd Director 13 Mar 2015 Past
Pramod Abcsdd Director 15 Apr 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akums Drugs And Pharmaceuticals.

Akums Drugs And Pharmaceuticals Limited, for the financial year ended 2025, experienced Minor drop in revenue, with a 6.65% decrease. The company also saw a substantial improvement in profitability, with a 197.31% increase in profit. The company's net worth Soared by an impressive increase of 1502.23%.

Akums Drugs And Pharmaceuticals revenue growth over time
Akums Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-6.65%
*******
*******
*******
*******
Revenue from Operations
*******
-9.16%
*******
*******
*******
*******
Total Assets
*******
28.13%
*******
*******
*******
*******
Profit or Loss
*******
197.31%
*******
*******
*******
*******
Net Worth
*******
1502.23%
*******
*******
*******
*******
EBITDA
*******
209.35%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akums Drugs And Pharmaceuticals?

In 2024, Akums Drugs And Pharmaceuticals had a promoter holding of 84.87% and a public holding of 15.13%. The company had 14 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,450,000,000.00

Satisfied Charges

₹4,683,850,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 245.00 Cr
Latest Charge Details
Date Lender Amount Status
08 Feb 2023 Sbicap Trustee Company Limited ₹245.00 Cr Open
15 Jul 2022 Yes Bank Limited ₹60.00 Cr Satisfied
13 Jul 2022 The Hongkong And Shanghai Banking Corporation Limited ₹50.00 Cr Satisfied
11 Apr 2022 Citi Bank N.A. ₹25.00 Cr Satisfied
16 Aug 2021 Hdfc Bank Limited ₹60.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Akums Drugs And Pharmaceuticals?

Akums Drugs And Pharmaceuticals has a workforce of 1575 employees as of Nov 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Akums Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akums Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akums Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Sbicap Trustee Company Limited of Rs. 245.00 Cr registered on 08 Feb 2023 with Charge ID 100679965 was modified on 01 Aug 2025. was completed.

  • Charges

    A charge registered on 03 Feb 2020 via Charge ID 100322967 with Others was fully satisfied on 29 Jul 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Akums Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 18 Jul 2025 as per latest MCA records. was completed.

  • Director Appointment

    Progress on Anilkumar Arvindlal Amin was appointed as a Director was appointed as a Director on 04 Jun 2025 & has been associated with this company since 8 months 24 days . was documented.

  • Balance Sheet

    Akums Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Sanjay Sinha was appointed as a Whole-time director was appointed as a Whole-time director on 17 Jan 2024 & has been associated with this company since 2 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Akums Drugs And Pharmaceuticals Limited?

The CIN of Akums Drugs And Pharmaceuticals Limited is L24239DL2004PLC125888.

Where is Akums Drugs And Pharmaceuticals Limited headquartered?

Akums Drugs And Pharmaceuticals Limited is headquartered at 304 Mohan Placelsc Saraswati Vihar, Delhi, Delhi, 110034.

When was Akums Drugs And Pharmaceuticals Limited incorporated?

Akums Drugs And Pharmaceuticals Limited was incorporated on 19 April 2004.

Who are the current directors of Akums Drugs And Pharmaceuticals Limited?

The current directors of Akums Drugs And Pharmaceuticals Limited are

What is the primary industry of Akums Drugs And Pharmaceuticals Limited?

The primary industry of Akums Drugs And Pharmaceuticals Limited is Manufacturing.

Is Akums Drugs And Pharmaceuticals Limited a listed company?

Akums Drugs And Pharmaceuticals Limited is listed.

What is the capital structure of Akums Drugs And Pharmaceuticals Limited?

The authorized capital of Akums Drugs And Pharmaceuticals Limited is ₹40.00 Cr, and the paid-up capital is ₹31.48 Cr.

What is the compliance status of Akums Drugs And Pharmaceuticals Limited?

The compliance status of Akums Drugs And Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available